Fogarty et al. demonstrate that despite treatment with hydroxycarbamide or blood transfusion, a proportion of children with sickle cell disease (HbSS) had persistently elevated vWF antigen and activity, as well as elevated vWF propeptide consistent with acute endothelial cell activation [63]. This evidence concerns the gene VWF and sickle cell disease.